Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial

Journal:

The Lancet Oncology

Published:

2025-11-26

DOI:

10.1016/s1470-2045(25)00492-9

Affiliations:

24

Authors:

39

Go to article

Institutions	Authors	Share
Sunnybrook Health Sciences Centre, U of T, Canada	8.666667	0.22
Brigham and Women's Hospital (BWH), United States of America (USA)	8.166667	0.21
University of Maryland, Baltimore (UMB), United States of America (USA)	7.166667	0.18
West Virginia University (WVU), United States of America (USA)	4.000000	0.10
Marlene and Stewart Greenebaum Comprehensive Cancer Center, United States of America (USA)	2.500000	0.06
University of Toronto (U of T), Canada	2.333333	0.06
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)	1.500000	0.04
Columbia University in the City of New York (CU), United States of America (USA)	1.000000	0.03
University of Virginia (UVA), United States of America (USA)	1.000000	0.03
Harvard Medical School (HMS), United States of America (USA)	0.833333	0.02
Harvard University, United States of America (USA)	0.500000	0.01
Johns Hopkins University (JHU), United States of America (USA)	0.500000	0.01
Massachusetts College of Pharmacy and Health Sciences (MCPHS), United States of America (USA)	0.500000	0.01
Montreal Neurological Institute and Hospital (MNI), McGill University, Canada	0.333333	0.01

Interested in Medical Biotechnology?